Bain Capital Life Sciences Investors, LLC sold HTFL
April 30, 2026 · Form 4 insider transaction
Bain Capital Life Sciences Investors, LLC sold 892,533 shares of Heartflow, Inc. at $29.18 per share, a transaction worth $26.04M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.995, inclusive.; Represents securities held directly by BCLS Fund III Investments, LP ("BCLS Fund III Investments").; Bain Capital Life Sciences Investors, LLC ("BCLSI") is the manager of Bain Capital Life Sciences III General Partner, LLC ("BCLS Fund III GP"), which is the general partner of Bain Capital Life Sciences Fund III, L.P. ("BCLS Fund III"), which is the managing member of BCLS Fund III Investments GP, LLC ("BCLS Fund III Investments GP"), which is the general partner of BCLS Fund III Investments. As a result, each of BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III Investments. BCLSI, BCLS Fund III GP, BCLS Fund III and BCLS Fund III Investments GP each disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.